Management of stage T1 tumors of the bladder: International Consensus Panel.
about
Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladderBacillus Calmette-Guérin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive DiseaseMolecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosisPredicting tumor outcomes in urothelial bladder carcinoma: turning pathways into clinical biomarkers of prognosis.Bacillus Calmette-Guérin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive DiseaseOptimal management of high-risk T1G3 bladder cancer: a decision analysisPrognostic role of substaging in T1G3 transitional cell carcinoma of the urinary bladderComplications associated with single-dose, perioperative mitomycin-C for patients undergoing bladder tumor resection.Saudi oncology society and Saudi urology association combined clinical management guidelines for urothelial urinary bladder cancer.Saudi Oncology Society clinical management guidelines for urinary bladder cancer.Surveillance and treatment of non-muscle-invasive bladder cancer in the USA.p53 status correlates with the risk of progression in stage T1 bladder cancer: a meta-analysisManagement of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?Bladder cancer: a review of non-muscle invasive disease.Developments in intravesical therapy for non-muscle-invasive bladder cancer.Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment.Bladder tumours: time for a paradigm shift?Intravesical therapy for urothelial carcinoma of the bladder.High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment.Follow-up procedures for non-muscle-invasive bladder cancer: an update.Current intravesical therapy for non-muscle invasive bladder cancer.Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group.Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature and recommendations.Tackling non-muscle invasive bladder cancer in the clinic.Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.Optimal timing of radical cystectomy in T1 high-grade bladder cancer.Tumour stage on re-staging transurethral resection predicts recurrence and progression-free survival of patients with high-risk non-muscle invasive bladder cancer.Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin.Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer.Conceptualizing global health-related quality of life in bladder cancer.Radical cystectomy for BCG failure: has the timing improved in recent years?Prognostic impact of preoperative hematological disorders and a risk stratification model in bladder cancer patients treated with radical cystectomy.Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer.Re-examination of the natural history of high-grade T1 bladder cancer using a large contemporary cohort.Implementing risk-aligned bladder cancer surveillance care.Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder.Essential content of evidence-based clinical practice guidelines for bladder cancer: The Japanese Urological Association 2015 update.Clinical value of PTEN in patients with superficial bladder cancer.Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder 2017.Biopsy Strategies in the Analysis of Urologic Neoplasia
P2860
Q26747775-370D177F-F081-4505-B52A-357BA5F0ABD9Q27011829-46433B33-8830-4CE4-B01F-4133B5AC1247Q30439612-DA98B611-89A7-4486-8900-CAD361114B92Q30446429-269149FC-D119-4F60-87BD-418CE8882F3AQ31112248-BDD44ABF-4CDD-49FA-A1E9-EDB949731AE2Q33300413-4DD50D7E-0CB2-455E-9DB5-F8ABA62A6071Q33733739-4A15E79D-FBCE-49C2-A84C-2A7D7E8A98E9Q34026715-F732625C-8516-4F26-BF70-E28102C81134Q34437299-EE275174-2E56-4885-B925-A5B1CACFC86DQ34997367-AC79A255-9B89-444F-8909-4134DEE37C33Q35977496-490C6ABD-4E20-493B-9EB8-701867DB93FFQ36853654-8D4981AC-C715-49D5-A46E-A999CD312E66Q37053829-9DB80874-59E6-4A7F-9663-C0F41962C1BCQ37791398-95901B9B-3CFE-4DE5-987A-23282FE82E55Q37812604-14009DA1-E33B-41ED-A23D-37ED5A03956CQ37833152-A030EBFD-FA7A-48A0-868F-8EBE4F833163Q37868801-9A920965-CE79-4185-B206-798CD7EDC58DQ37911278-A2475006-1F66-453E-87E0-08BD7DD77976Q38052445-4DA212D6-8D98-4E53-858E-BA1F92F11DDDQ38055500-7B69BF7B-DAB8-4F88-BB28-01C9F346B007Q38129947-4B5127E1-28CB-47A3-BB04-480A44DA4914Q38711963-099638DE-D37A-4873-8FC3-4303E8D511DAQ38801252-9D628905-985A-4F75-A06C-39E63F018FCFQ39209020-354B4550-E598-49FC-B61A-7AB6CB8F9D91Q39636631-6154C404-3BCE-4832-8051-813A5079F3AFQ39813009-2677F3D9-F51E-4330-8C32-639A19DC9D4FQ40100639-65103819-B2B8-4E80-AE0E-FF1669DBB44EQ42497557-C3B7CF39-7EEE-49EA-9CAA-7F4F56C26BADQ42971182-572AEFEB-5912-4113-B7D0-DA52FC141DC9Q45961302-29CF330A-4EA3-4376-8C4D-E7D53E1AB2FDQ46216660-54938B9A-4AE5-4C8B-AB06-0A75F04AB0A8Q46569857-9CDC9CC6-9E09-4C96-BDD0-4E5A4B85A65FQ47292033-FC2FE70D-F03F-4879-8787-0318FCDA9189Q48288809-4B637D56-A362-49B2-84DE-7965F7C2C139Q48507562-E2EB7A6B-61F8-4F5A-A6E9-E66150DFCFD6Q50014325-0C1DE08D-C419-4A14-81CA-2ACBC015D620Q50199772-7662683E-24CD-4D8A-BA38-B54382FB30EDQ53540396-B8791C87-0561-4BD2-BD51-2D904AC37042Q55013973-42395E89-6342-4E01-B66A-EA12FA60830DQ57766033-259563D3-B38A-4D03-A039-3646CE1422D2
P2860
Management of stage T1 tumors of the bladder: International Consensus Panel.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Management of stage T1 tumors of the bladder: International Consensus Panel.
@ast
Management of stage T1 tumors of the bladder: International Consensus Panel.
@en
type
label
Management of stage T1 tumors of the bladder: International Consensus Panel.
@ast
Management of stage T1 tumors of the bladder: International Consensus Panel.
@en
prefLabel
Management of stage T1 tumors of the bladder: International Consensus Panel.
@ast
Management of stage T1 tumors of the bladder: International Consensus Panel.
@en
P2093
P1433
P1476
Management of stage T1 tumors of the bladder: International Consensus Panel
@en
P2093
Alan M Nieder
Donald Lamm
Kyouichi Tomita
Maurizio Brausi
Michael A S Jewett
P304
P356
10.1016/J.UROLOGY.2005.08.066
P407
P433
P577
2005-12-01T00:00:00Z